Key facts
- It has raised $2.4M; the latest was Seed Round ($2.4M) in Jun 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Nápreva
- ·The full record, as it builds
Funding rounds
No funding rounds for Nápreva are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nápreva
Manufacturer of terpene-based products intended to address chronic pain, stress, and sleep challenges in humans and animals. The company offers plant-based ingredients, verified safety standards, and solvent-free processing, enabling individuals and pet owners to manage persistent conditions with reduced exposure to synthetic compounds.
- Sector
- Healthcare
- HQ
- Scottsdale, AZ, United States
- Founded
- 2014
- Employees
- 4
- Website
- napreva.com/
- Ownership
- Privately Held (backing)
Nápreva doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nápreva shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nápreva in its N-PORT filings yet. We sweep new filings monthly.